On 14 November 2011 the European Commission published its decision in favour of CreaNutrition AG. The decision was in respect of Article 14 of the EC Regulation on the labelling of foodstuffs with nutrition and health claim statements permitting oat beta-glucan to be described as beneficial to health.

Following the opinion of the Panel on Dietetic Products, Nutrition and Allergies (NDA) the EFSA and the Regulation (EU) no. 1160/2011 of the Commission, foodstuffs through which 3g/day of oat beta-glucan are consumed (1g of oat beta-glucan per portion) are allowed to display the following health claim:
«Oat beta-glucan reduces the cholesterol level in the blood. The lowering of the blood cholesterol level can reduce the risk of coronary heart disease.»

Document of the EFSA: Offical-Journal-EU (700kB)